UCSD poised to enter $30 million deal with MTS - CBS News 8 - San Diego, CA News Station - KFMB Channel 8

UCSD poised to enter $30 million deal with MTS

Posted: Updated:

SAN DIEGO (CNS) - UC San Diego Health and the Metropolitan Transit System Thursday announced a 30-year naming rights deal for the planned 11-mile extension of the trolley system's Blue Line.
   
UCSD will spend $675,000 in the first year of the agreement, with future increases tied to inflation and the start of service.
   
Construction on the "UC San Diego Blue Line" is scheduled to begin early next year and take four years to complete, according to the MTS.
   
The line already runs from San Ysidro to Old Town. When the $2 billion extension is finished, trolleys will roll north along Interstate 5 to the UCSD campus before turning east to the Westfield UTC shopping mall.
   
"The health system has long been committed to playing an important and positive role in the life and lives of this region and its residents," said Paul Viviano, CEO of UC San Diego Health.
   
"This agreement is a figurative and literal reflection of that commitment," Viviano said. "It represents a new, smart and sustainable way for San Diegans to visit, learn and access the diverse services we offer."
   
Under the deal, the Old Town Transit Center will be renamed "Old Town UC San Diego Health South."
   
Future stations at the UC San Diego campus and its medical facilities will also be named for the health system.
   
"The UC San Diego Blue Line extension will not only provide a great new way to travel to campus, but UC San Diego Health will realize exceptional opportunities to increase awareness of its world-class medical facilities via the naming rights for 30 miles of light rail service," said MTS CEO Paul Jablonski.
   
MTS officials said funding will not come from state sources.

Powered by Frankly
All content © Copyright 2000 - 2017 Midwest Television, Inc. All Rights Reserved.
For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.